PEDBASE.org - The Pediatric Database -
Detailed information of ACUTE BRONCHIOLITIS
ACUTE BRONCHIOLITIS
DEFINITION:
An acute viral syndrome of the bronchioles characterized by
wheezing and respiratory distress.
EPIDEMIOLOGY:
- incidence: 10-15/1000 (most common LRI syndrome in young kids)
- age of onset:
- less than 2 yrs with peak between 6-10 weeks of age
- risk factors:
- winter -> early spring (RSV); fall (M. pneumoniae)
- M > F
- high risk patients:
- cardiopulmonary disease (CHF, CF, BPD)
- immunocomprimised
- trisomy 21
PATHOGENESIS:
- Respiratory Syncytial Virus (RSV)
2. Minor
- adenovirus types 7 & 21
- parainflenzae types 1 & 3
- influenzae A & B, enterovirus
- mycoplasma pneumoniae
2. Pathogenesis
- The infecting virus spreads from the upper respiratory tract
(prodrome) and invades the medium and small bronchi and
bron-chioles resulting in an inflammatory response consisting of
edema and exudate (mucous and cellular debris) and epithelial
necrosis. Since resistence to the airflow is inversely related
to the 4th power of the radius (Poiseuille's Law), even minor
thickening of the bronchiolar wall produces a profound effect on
airflow. Airway resistence in the smaller air passages increases
during both inspiration and expiration but since the radius of
the airway is smaller during expiration, the resulting
ball-valve respiratory obstruction leads to early air trapping
and overinflation. Atelectasis occurs when the obstruction
becomes complete and trapped air is absorbed.
- RSV is shed from the respiratory tract for an average of 9
days in children under 1 year of age and for up to months in
infants with immunodeficiency syndromes.
DIAGNOSIS:
1. Clinical
- age, season, clinical features
2. Laboratory
- viral (RSV) identification
CLINICAL FEATURES:
1. Prodrome
- mild URTI for several (1-4) days:
- rhinitis (serous nasal discharge)
- sneezing
- cough
- fever (38.5-39 C)
- anorexia with poor feeding
2. Respiratory Manifestations
- mild cases:
- gradual onset and resolves within 1-3 days
- paroxysmal wheezing cough
- worsening signs:
- sudden onset and protracted
- audible wheezing
- prolonged expiratory phase
- widespread fine end inspiratory, early expiratory crackles
- decreased breath sounds
- tachypnea (60-80 b/min)
- tachycardia (>200 b/min)
- hypoxia +/- cyanosis
- lethergy and apnea
- signs/symptoms of respiratory distress
3. Complications
1. Acute
- dehydration
- febrile seizures
- respiratory distress with prolonged apneic spells
- respiratory failure
- death (mortality rate <1% but if underlying disease this
is >1%)
2. Chronic
1. RSV Bronchiolitis
- asthma
- strong association between proven RSV bronchiolitis
and subsequent development of asthma - about 30-50% of
those with RSV bronchiolitis go on to develop asthma
- may find an increased anti-RSV IgE antibody titre
during an acute RSV infection
2. Adenovirus Bronchiolitis
- bronchiolitis obliterans (chronic bronchiolitis)
- unilateral hyperlucent lung syndrome
4. Prognosis
1. Acute Course
- 80% of cases will be clinically improved within 3-4 days
of initial presentation (recovery usually dramatic)
- blood gases normalize over the next 2 weeks
- radiologic changes normalize over 9 weeks
2. Prolonged Course
- 20% of cases will have a protracted course lasting from
weeks to months
- persistent wheezing and hyperinflation
- abnormal gas exchange and lung function
- some develop lobar collapse
INVESTIGATIONS:
1. Serum
1. CBC
- WBC (5-24), may have increased PMN and bands
2. Blood Gas
- hypoxia due to V/Q mismatch
- metabolic acidosis (if dehydrated)
3. Others
- lytes, BUN, creatinine (dehydration)
2. Imaging Studies
1. Chest X-Ray
- scattered areas of consolidation, segmental collapse and/
or patchy atelectasis
- hyperinflation - flattened diaphragms with increased AP
diameter
- peribronchial thickening
- rule out CHF, foreign bodies, BPD, bacterial pneumonia
3. Virology
- nasopharyngeal aspirate for RSV or other viruses
- culture and rapid antigen detection techniques
MANAGEMENT:
- depends upon the degree of severity:
1. Mild
- noisy breathing with no distress
- send home if parents are good and a close distance
- instructions:
- sleep in propped up position
- cool mist humidifier
- oral rehydration if dehydrated
2. Moderate
- moderate respiratory distress +/- apneic spells or
cyanosis
- high risk patient
- admit to hospital with:
- humidified oxygen
- saturation moniter for hypoxia
- apnea and blood gas monitering
- careful temperature control
- oral/IV rehydration
3. Severe
- severe respiratory distress or failure
- admit to ICU:
- intubate and ventilate for mean of 5 days
- ribavirin
1. Humidified Oxygen
- proposed mechanism of action:
- relieves hypoxia, dyspnea, and cyanosis
- decreases the insensible water loss from tachypnea
- dose:
- humidified 35-40% oxygen by mask or hood box
2. Ribavirin (Virazole)
- proposed mechanism of action:
- a synthetic antiviral agent directed against viral DNA
- this guanine analog prevents viral replication
- effect:
- shortens the clinical course
- reduces the severity of bronchiolitis if administered
early in the course of the disease
- dose:
- continuous inhalation as a small particle mist for
12-20 hours per 24 hours for 3-5 days
- indications:
- see Committee on Infectious Diseases, 1987
- high risk patients
3. Antibiotics
- not indicated unless evidence of secondary bacterial
infection:
- clinical deterioration +/- sepsis
- tracheal secretions positive on gram stain or C&S
- significant increase in WBC count and left shift
4. Bronchodilators/Steriods
- use in Bronchiolitis is controversial
- Salbutamol 0.04 cc/kg (up to 1cc) per dose of inhalation
solution diluted in 2cc normal saline q4h with q2h prn -
continue to use only if effective (i.e., decreased wheezing
after a treatment)
5. Experimental
- immunotherapy - human IgG against RSV
|
Pediatric Database - ACUTE BRONCHIOLITIS
Pediatric Organization - Pedbase [at] Gmail.com